Advances in microRNA experimental approaches to study physiological regulation of gene products implicated in CNS disorders

Experimental Neurology

Volumn 235, Issue 2, 2012, Pages 402-418

  Long, Justin M ^a   Lahiri, Debomoy K ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Alzheimer; HITS CLIP; Method; Non coding RNA; PAR CLIP; Post transcriptional; Predictors; RIP Chip

Indexed keywords

ARGONAUTE PROTEIN; MICRORNA;

ALGORITHM; ALZHEIMER DISEASE; ANTISENSE THERAPY; BIOINFORMATICS; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM FUNCTION; COMPUTER PROGRAM; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE PRODUCT; GENE REGULATORY NETWORK; GENE TARGETING; GENETIC ANALYSIS; GENETIC REGULATION; HIGH THROUGHPUT SEQUENCING; HIGH THROUGHPUT SEQUENCING OF RNA ISOLATED BY CROSSLINKING AND IMMUNOPRECIPITATION; HUMAN; IN SITU HYBRIDIZATION; MICROARRAY ANALYSIS; MICROCHIP ANALYSIS; MOLECULAR INTERACTION; NONHUMAN; NORTHERN BLOTTING; NUCLEIC ACID ANALYSIS; PATHOPHYSIOLOGY; PHOTOACTIVATABLE RIBONUCLEOSIDE ENHANCED CROSSLINKING AND IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RIBONUCLEOPROTEIN IMMUNOPRECIPITATION; RNA INTERFERENCE; RNA METABOLISM; RNA PROCESSING; RNA STABILITY; RNA SYNTHESIS; TANDEM AFFINITY PURIFICATION; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; VALIDATION PROCESS;

ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; GENE TARGETING; HUMANS; MICRORNAS;

EID: 84860386287     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.12.043     Document Type: Review

References (206)

1. Alley G.M., Bailey J.A., Chen D., Ray B., Puli L.K., Tanila H., Banerjee P.K., Lahiri D.K. Memantine lowers amyloid-beta peptide levels in neuronal cultures and in APP/PS1 transgenic mice. J. Neurosci. Res. 2010, 88:143-154.
2. Alvarez-Erviti L., Seow Y., Yin H., Betts C., Lakhal S., Wood M.J.A. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 2011, 29:341-345.
3. Andreasen D., Fog J.U., Biggs W., Salomon J., Dahslveen I.K., Baker A., Mouritzen P. Improved microRNA quantification in total RNA from clinical samples. Methods 2010, 50:S6-S9.
4. Babak T., Zhang W., Morris Q., Blencowe B.J., Hughes T.R. Probing microRNAs with microarrays: tissue specificity and functional inference. RNA 2004, 10:1813-1819.
5. Babiarz J.E., Hsu R., Melton C., Thomas M., Ullian E.M., Blelloch R. A role for noncanonical microRNAs in the mammalian brain revealed by phenotypic differences in Dgcr8 versus Dicer1 knockouts and small RNA sequencing. RNA 2011, 17:1489-1501.
6. Baek D., Villén J., Shin C., Camargo F.D., Gygi S.P., Bartel D.P. The impact of microRNAs on protein output. Nature 2008, 455:64-71.
7. Bailey J.A., Ray B., Greig N.H., Lahiri D.K. Rivastigmine lowers Aβ and increases sAPPα levels, which parallel elevated synaptic markers and metabolic activity in degenerating primary rat neurons. PLoS One 2011, 6:e21954.
8. Balcells I., Cirera S., Busk P.K. Specific and sensitive quantitative RT-PCR of miRNAs with DNA primers. BMC Biotechnol. 2011, 11:70.
9. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
10. Baskerville S., Bartel D.P. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 2005, 11:241-247.
11. Becker R.E., Greig N.H. Why so few drugs for Alzheimer's disease? Are methods failing drugs?. Curr. Alzheimer Res. 2010, 7:642-651.
12. Becker C., Hammerle-Fickinger A., Riedmaier I., Pfaffl M.W. mRNA and microRNA quality control for RT-qPCR analysis. Methods 2010, 50:237-243.
13. Behlke M.A., Dames S.A., McDonald W.H., Gould K.L., Devor E.J., Walder J.A. Use of high specific activity StarFire oligonucleotide probes to visualize low-abundance pre-mRNA splicing intermediates in S. pombe. Biotechniques 2000, 29:892-897.
14. Beitzinger M., Peters L., Zhu J.Y., Kremmer E., Meister G. Identification of human microRNA targets from isolated argonaute protein complexes. RNA Biol. 2007, 4:76-84.
15. Benes V., Castoldi M. Expression profiling of microRNA using real-time quantitative PCR, how to use it and what is available. Methods 2010, 50:244-249.
16. Bertram L., Lill C.M., Tanzi R.E. The genetics of Alzheimer disease: back to the future. Neuron 2010, 68:270-281.
17. Betel D., Wilson M., Gabow A., Marks D.S., Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2008, 36:D149-D153.
18. Betel D., Koppal A., Agius P., Sander C., Leslie C. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol. 2010, 11:R90.
19. Burroughs A.M., Kawano M., Ando Y., Daub C.O., Hayashizaki Y. pre-miRNA profiles obtained through application of locked nucleic acids and deep sequencing reveals complex 5'/3' arm variation including concomitant cleavage and polyuridylation patterns. Nucleic Acids Res. 2011, doi:10.1093/nar/gkr903.
20. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., Mueller R., Nolan T., Pfaffl M.W., Shipley G.L., Vandesompele J., Wittwer C.T. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 2009, 55:611-622.
21. Bustin S.A., Beaulieu J.-F., Huggett J., Jaggi R., Kibenge F.S.B., Olsvik P.A., Penning L.C., Toegel S. MIQE précis: practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments. BMC Mol. Biol. 2010, 11:74.
22. Castoldi M., Schmidt S., Benes V., Noerholm M., Kulozik A.E., Hentze M.W., Muckenthaler M.U. A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA). RNA 2006, 12:913-920.
23. Chatterjee S., Grosshans H. Active turnover modulates mature microRNA activity in Caenorhabditis elegans. Nature 2009, 461:546-549.
24. Chen C., Ridzon D.A., Broomer A.J., Zhou Z., Lee D.H., Nguyen J.T., Barbisin M., Xu N.L., Mahuvakar V.R., Andersen M.R., Lao K.Q., Livak K.J., Guegler K.J. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005, 33:e179.
25. Chendrimada T.P., Gregory R.I., Kumaraswamy E., Norman J., Cooch N., Nishikura K., Shiekhattar R. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005, 436:740-744.
26. Chi S.W., Zang J.B., Mele A., Darnell R.B. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 2009, 460:479-486.
27. Choi W.-Y., Giraldez A.J., Schier A.F. Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430. Science 2007, 318:271-274.
28. Cogswell J.P., Ward J., Taylor I.A., Waters M., Shi Y., Cannon B., Kelnar K., Kemppainen J., Brown D., Chen C., Prinjha R.K., Richardson J.C., Saunders A.M., Roses A.D., Richards C.A. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J. Alzheimers Dis. 2008, 14:27-41.
29. Davis T.H., Cuellar T.L., Koch S.M., Barker A.J., Harfe B.D., McManus M.T., Ullian E.M. Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. J. Neurosci. 2008, 28:4322-4330.
30. Deo M., Yu J.-Y., Chung K.-H., Tippens M., Turner D.L. Detection of mammalian microRNA expression by in situ hybridization with RNA oligonucleotides. Dev. Dyn. 2006, 235:2538-2548.
31. Easow G., Teleman A.A., Cohen S.M. Isolation of microRNA targets by miRNP immunopurification. RNA 2007, 13:1198-1204.
32. Ebert M.S., Sharp P.A. MicroRNA sponges: progress and possibilities. RNA 2010, 16:2043-2050.
33. Ebert M.S., Neilson J.R., Sharp P.A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 2007, 4:721-726.
34. Elmén J., Lindow M., Silahtaroglu A., Bak M., Christensen M., Lind-Thomsen A., Hedtjärn M., Hansen J.B., Hansen H.F., Straarup E.M., McCullagh K., Kearney P., Kauppinen S. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res. 2008, 36:1153-1162.
35. Enright A.J., John B., Gaul U., Tuschl T., Sander C., Marks D.S. MicroRNA targets in Drosophila. Genome Biol. 2003, 5:R1.
36. Esau C., Davis S., Murray S.F., Yu X.X., Pandey S.K., Pear M., Watts L., Booten S.L., Graham M., McKay R., Subramaniam A., Propp S., Lollo B.A., Freier S., Bennett C.F., Bhanot S., Monia B.P. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006, 3:87-98.
37. Faghihi M.A., Zhang M., Huang J., Modarresi F., Van der Brug M.P., Nalls M.A., Cookson M.R., St-Laurent G., Wahlestedt C. Evidence for natural antisense transcript-mediated inhibition of microRNA function. Genome Biol. 2010, 11:R56.
38. Fan X., Liu Y., Jiang J., Ma Z., Wu H., Liu T., Liu M., Li X., Tang H. miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells. Acta Biochim. Biophys. Sin. (Shanghai) 2010, 42:318-324.
39. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat. Rev. Genet. 2008, 9:102-114.
40. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19:92-105.
41. Gantier M.P., McCoy C.E., Rusinova I., Saulep D., Wang D., Xu D., Irving A.T., Behlke M.A., Hertzog P.J., Mackay F., Williams B.R.G. Analysis of microRNA turnover in mammalian cells following Dicer1 ablation. Nucleic Acids Res. 2011, 39:5692-5703.
42. Ge Y.-W., Ghosh C., Song W., Maloney B., Lahiri D.K. Mechanism of promoter activity of the beta-amyloid precursor protein gene in different cell lines: identification of a specific 30 bp fragment in the proximal promoter region. J. Neurochem. 2004, 90:1432-1444.
43. Gehrke S., Imai Y., Sokol N., Lu B. Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature 2010, 466:637-641.
44. Git A., Dvinge H., Salmon-Divon M., Osborne M., Kutter C., Hadfield J., Bertone P., Caldas C. Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. RNA 2010, 16:991-1006.
45. Grimson A., Farh K.K.-H., Johnston W.K., Garrett-Engele P., Lim L.P., Bartel D.P. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 2007, 27:91-105.
46. Guo H., Ingolia N.T., Weissman J.S., Bartel D.P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010, 466:835-840.
47. Hafner M., Landgraf P., Ludwig J., Rice A., Ojo T., Lin C., Holoch D., Lim C., Tuschl T. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008, 44:3-12.
48. Hafner M., Landthaler M., Burger L., Khorshid M., Hausser J., Berninger P., Rothballer A., Ascano M., Jungkamp A.-C., Munschauer M., Ulrich A., Wardle G.S., Dewell S., Zavolan M., Tuschl T. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 2010, 141:129-141.
49. Hafner M., Landthaler M., Burger L., Khorshid M., Hausser J., Berninger P., Rothballer A., Ascano M., Jungkamp A.-C., Munschauer M., Ulrich A., Wardle G.S., Dewell S., Zavolan M., Tuschl T. PAR-CliP-a method to identify transcriptome-wide the binding sites of RNA binding proteins. J. Vis. Exp. 2010, 41:e2034.
50. Hafner M., Renwick N., Brown M., Mihailović A., Holoch D., Lin C., Pena J.T.G., Nusbaum J.D., Morozov P., Ludwig J., Ojo T., Luo S., Schroth G., Tuschl T. RNA-ligase-dependent biases in miRNA representation in deep-sequenced small RNA cDNA libraries. RNA 2011, 17:1697-1712.
51. Han J., Lee Y., Yeom K.-H., Kim Y.-K., Jin H., Kim V.N. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev. 2004, 18:3016-3027.
52. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
53. Hausser J., Landthaler M., Jaskiewicz L., Gaidatzis D., Zavolan M. Relative contribution of sequence and structure features to the mRNA binding of Argonaute/EIF2C-miRNA complexes and the degradation of miRNA targets. Genome Res. 2009, 19:2009-2020.
54. Hébert S.S., Horré K., Nicolaï L., Papadopoulou A.S., Mandemakers W., Silahtaroglu A.N., Kauppinen S., Delacourte A., De Strooper B. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:6415-6420.
55. Hébert S.S., Horré K., Nicolaï L., Bergmans B., Papadopoulou A.S., Delacourte A., De Strooper B. MicroRNA regulation of Alzheimer's amyloid precursor protein expression. Neurobiol. Dis. 2009, 33:422-428.
56. Hébert S.S., Papadopoulou A.S., Smith P., Galas M.-C., Planel E., Silahtaroglu A.N., Sergeant N., Buée L., De Strooper B. Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum. Mol. Genet. 2010, 19:3959-3969.
57. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res. 1996, 6:986-994.
58. Hendrickson D.G., Hogan D.J., Herschlag D., Ferrell J.E., Brown P.O. Systematic identification of mRNAs recruited to argonaute 2 by specific microRNAs and corresponding changes in transcript abundance. PLoS One 2008, 3:e2126.
59. Hendrickson D.G., Hogan D.J., McCullough H.L., Myers J.W., Herschlag D., Ferrell J.E., Brown P.O. Concordant regulation of translation and mRNA abundance for hundreds of targets of a human microRNA. PLoS Biol. 2009, 7:e1000238.
60. Heo I., Joo C., Cho J., Ha M., Han J., Kim V.N. Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol. Cell 2008, 32:276-284.
61. Heo I., Joo C., Kim Y.-K., Ha M., Yoon M.-J., Cho J., Yeom K.-H., Han J., Kim V.N. TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. Cell 2009, 138:696-708.
62. Hong X., Hammell M., Ambros V., Cohen S.M. Immunopurification of Ago1 miRNPs selects for a distinct class of microRNA targets. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:15085-15090.
63. Hsu R.-J., Tsai H.-J. Performing the Labeled microRNA pull-down (LAMP) assay system: an experimental approach for high-throughput identification of microRNA-target mRNAs. Methods Mol. Biol. 2011, 764:241-247.
64. Hsu R.-J., Yang H.-J., Tsai H.-J. Labeled microRNA pull-down assay system: an experimental approach for high-throughput identification of microRNA-target mRNAs. Nucleic Acids Res. 2009, 37:e77.
65. Hutvágner G., McLachlan J., Pasquinelli A.E., Bálint E., Tuschl T., Zamore P.D. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 2001, 293:834-838.
66. Hutvágner G., Simard M.J., Mello C.C., Zamore P.D. Sequence-specific inhibition of small RNA function. PLoS Biol. 2004, 2:E98.
67. Hwang H.-W., Wentzel E.A., Mendell J.T. Cell-cell contact globally activates microRNA biogenesis. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:7016-7021.
68. Ikeda K., Satoh M., Pauley K.M., Fritzler M.J., Reeves W.H., Chan E.K.L. Detection of the argonaute protein Ago2 and microRNAs in the RNA induced silencing complex (RISC) using a monoclonal antibody. J. Immunol. Methods 2006, 317:38-44.
69. John B., Enright A.J., Aravin A., Tuschl T., Sander C., Marks D.S. Human MicroRNA targets. PLoS Biol. 2004, 2:e363.
70. Jørgensen S., Baker A., Møller S., Nielsen B.S. Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes. Methods 2010, 52:375-381.
71. Kai Z.S., Pasquinelli A.E. MicroRNA assassins: factors that regulate the disappearance of miRNAs. Nat. Struct. Mol. Biol. 2010, 17:5-10.
72. Karginov F.V., Conaco C., Xuan Z., Schmidt B.H., Parker J.S., Mandel G., Hannon G.J. A biochemical approach to identifying microRNA targets. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:19291-19296.
73. Katoh T., Sakaguchi Y., Miyauchi K., Suzuki T., Kashiwabara S.-I., Baba T., Suzuki T. Selective stabilization of mammalian microRNAs by 3' adenylation mediated by the cytoplasmic poly(A) polymerase GLD-2. Genes Dev. 2009, 23:433-438.
74. Kertesz M., Iovino N., Unnerstall U., Gaul U., Segal E. The role of site accessibility in microRNA target recognition. Nat. Genet. 2007, 39:1278-1284.
75. Kim S.W., Li Z., Moore P.S., Monaghan A.P., Chang Y., Nichols M., John B. A sensitive non-radioactive northern blot method to detect small RNAs. Nucleic Acids Res. 2010, 38:e98.
76. Kiriakidou M., Nelson P.T., Kouranov A., Fitziev P., Bouyioukos C., Mourelatos Z., Hatzigeorgiou A. A combined computational-experimental approach predicts human microRNA targets. Genes Dev. 2004, 18:1165-1178.
77. Kloosterman W.P., Wienholds E., de Bruijn E., Kauppinen S., Plasterk R.H.A. In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes. Nat. Methods 2006, 3:27-29.
78. Konopka W., Kiryk A., Novak M., Herwerth M., Parkitna J.R., Wawrzyniak M., Kowarsch A., Michaluk P., Dzwonek J., Arnsperger T., Wilczynski G., Merkenschlager M., Theis F.J., Köhr G., Kaczmarek L., Schütz G. MicroRNA loss enhances learning and memory in mice. J. Neurosci. 2010, 30:14835-14842.
79. Krause J.E., Chenard B.L. Opportunities and challenges in the discovery of new central nervous system drugs. Ann. N. Y. Acad. Sci. 2008, 1144:243-250.
80. Krek A., Grün D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., MacMenamin P., da Piedade I., Gunsalus K.C., Stoffel M., Rajewsky N. Combinatorial microRNA target predictions. Nat. Genet. 2005, 37:495-500.
81. Krichevsky A.M., King K.S., Donahue C.P., Khrapko K., Kosik K.S. A microRNA array reveals extensive regulation of microRNAs during brain development. RNA 2003, 9:1274-1281.
82. Krol J., Busskamp V., Markiewicz I., Stadler M.B., Ribi S., Richter J., Duebel J., Bicker S., Fehling H.J., Schübeler D., Oertner T.G., Schratt G., Bibel M., Roska B., Filipowicz W. Characterizing light-regulated retinal microRNAs reveals rapid turnover as a common property of neuronal microRNAs. Cell 2010, 141:618-631.
83. Krützfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., Stoffel M. Silencing of microRNAs in vivo with "antagomirs". Nature 2005, 438:685-689.
84. Krützfeldt J., Kuwajima S., Braich R., Rajeev K.G., Pena J., Tuschl T., Manoharan M., Stoffel M. Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res. 2007, 35:2885-2892.
85. Kurreck J., Wyszko E., Gillen C., Erdmann V.A. Design of antisense oligonucleotides stabilized by locked nucleic acids. Nucleic Acids Res. 2002, 30:1911-1918.
86. Lagos-Quintana M., Rauhut R., Lendeckel W., Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001, 294:853-858.
87. Lahiri D.K. Application of a multidisciplinary approach to Alzheimer's disease to develop novel drug targets by integrating biomarkers, imaging, genetic and molecular strategies. Curr. Alzheimer Res. 2011, 8:1-3.
88. Lahiri D.K., Nall C. Promoter activity of the gene encoding the beta-amyloid precursor protein is up-regulated by growth factors, phorbol ester, retinoic acid and interleukin-1. Brain Res. Mol. Brain Res. 1995, 32:233-240.
89. Lahiri D.K., Robakis N.K. The promoter activity of the gene encoding Alzheimer beta-amyloid precursor protein (APP) is regulated by two blocks of upstream sequences. Brain Res. Mol. Brain Res. 1991, 9:253-257.
90. Lahiri D.K., Farlow M.R., Sambamurti K., Greig N.H., Giacobini E., Schneider L.S. A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease. Curr. Drug Targets 2003, 4:97-112.
91. Lahiri D.K., Ge Y.-W., Maloney B. Characterization of the APP proximal promoter and 5'-untranslated regions: identification of cell type-specific domains and implications in APP gene expression and Alzheimer's disease. FASEB J. 2005, 19:653-655.
92. Lahiri D.K., Maloney B., Zawia N.H. The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases. Mol. Psychiatry 2009, 14:992-1003.
93. Lam L.T., Lu X., Zhang H., Lesniewski R., Rosenberg S., Semizarov D. A microRNA screen to identify modulators of sensitivity to BCL2 inhibitor ABT-263 (navitoclax). Mol. Cancer Ther. 2010, 9:2943-2950.
94. Landthaler M., Gaidatzis D., Rothballer A., Chen P.Y., Soll S.J., Dinic L., Ojo T., Hafner M., Zavolan M., Tuschl T. Molecular characterization of human Argonaute-containing ribonucleoprotein complexes and their bound target mRNAs. RNA 2008, 14:2580-2596.
95. Larsson E., Sander C., Marks D. mRNA turnover rate limits siRNA and microRNA efficacy. Mol. Syst. Biol. 2010, 6:433.
96. Lau N.C., Lim L.P., Weinstein E.G., Bartel D.P. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001, 294:858-862.
97. Lee R.C., Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001, 294:862-864.
98. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
99. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., Lee J., Provost P., Radmark O., Kim S., Kim V.N. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425:415-419.
100. Lee Y., Kim M., Han J., Yeom K.-H., Lee S., Baek S.H., Kim V.N. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004, 23:4051-4060.
101. Lennox K.A., Behlke M.A. A direct comparison of anti-microRNA oligonucleotide potency. Pharm. Res. 2010, 27:1788-1799.
102. Lewis B.P., Shih I.-hung, Jones-Rhoades M.W., Bartel D.P., Burge C.B. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798.
103. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
104. Lim L.P., Lau N.C., Garrett-Engele P., Grimson A., Schelter J.M., Castle J., Bartel D.P., Linsley P.S., Johnson J.M. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433:769-773.
105. Linsen S.E.V., de Wit E., Janssens G., Heater S., Chapman L., Parkin R.K., Fritz B., Wyman S.K., de Bruijn E., Voest E.E., Kuersten S., Tewari M., Cuppen E. Limitations and possibilities of small RNA digital gene expression profiling. Nat. Methods 2009, 6:474-476.
106. Linsley P.S., Schelter J., Burchard J., Kibukawa M., Martin M.M., Bartz S.R., Johnson J.M., Cummins J.M., Raymond C.K., Dai H., Chau N., Cleary M., Jackson A.L., Carleton M., Lim L. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol. Cell. Biol. 2007, 27:2240-2252.
107. Liu C.-G., Calin G.A., Meloon B., Gamliel N., Sevignani C., Ferracin M., Dumitru C.D., Shimizu M., Zupo S., Dono M., Alder H., Bullrich F., Negrini M., Croce C.M. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:9740-9744.
108. Liu W., Liu C., Zhu J., Shu P., Yin B., Gong Y., Qiang B., Yuan J., Peng X. MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice. Neurobiol. Aging 2010, 10.1016/j.neurobiolaging.2010.04.034.
109. Long J.M., Lahiri D.K. A novel microRNA interaction relevant to Alzheimer's disease pathogenesis and drug target discovery: miR-346 induces expression of amyloid precursor protein. Alzheimers Dement. 2011, 7:S566-S567.
110. Long J.M., Lahiri D.K. Current drug targets for modulating Alzheimer's amyloid precursor protein: role of specific micro-RNA species. Curr. Med. Chem. 2011, 18:3314-3321.
111. Long J.M., Lahiri D.K. MicroRNA-101 downregulates Alzheimer's amyloid-β precursor protein levels in human cell cultures and is differentially expressed. Biochem. Biophys. Res. Commun. 2011, 404:889-895.
112. Lu J., Tsourkas A. Imaging individual microRNAs in single mammalian cells in situ. Nucleic Acids Res. 2009, 37:e100.
113. Lukiw W.J. Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport 2007, 18:297-300.
114. Lund E., Güttinger S., Calado A., Dahlberg J.E., Kutay U. Nuclear export of microRNA precursors. Science 2004, 303:95-98.
115. Magill S.T., Cambronne X.A., Luikart B.W., Lioy D.T., Leighton B.H., Westbrook G.L., Mandel G., Goodman R.H. microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:20382-20387.
116. Maloney B., Ge Y.-W., Greig N., Lahiri D.K. Presence of a "CAGA box" in the APP gene unique to amyloid plaque-forming species and absent in all APLP-1/2 genes: implications in Alzheimer's disease. FASEB J. 2004, 18:1288-1290.
117. Mangialasche F., Solomon A., Winblad B., Mecocci P., Kivipelto M. Alzheimer's disease: clinical trials and drug development. Lancet Neurol. 2010, 9:702-716.
118. Maragkakis M., Alexiou P., Papadopoulos G.L., Reczko M., Dalamagas T., Giannopoulos G., Goumas G., Koukis E., Kourtis K., Simossis V.A., Sethupathy P., Vergoulis T., Koziris N., Sellis T., Tsanakas P., Hatzigeorgiou A.G. Accurate microRNA target prediction correlates with protein repression levels. BMC Bioinformatics 2009, 10:295.
119. Maragkakis M., Reczko M., Simossis V.A., Alexiou P., Papadopoulos G.L., Dalamagas T., Giannopoulos G., Goumas G., Koukis E., Kourtis K., Vergoulis T., Koziris N., Sellis T., Tsanakas P., Hatzigeorgiou A.G. DIANA-microT web server: elucidating microRNA functions through target prediction. Nucleic Acids Res. 2009, 37:W273-W276.
120. Mayr C., Bartel D.P. Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 2009, 138:673-684.
121. Mbella E.G., Bertrand S., Huez G., Octave J.N. A GG nucleotide sequence of the 3' untranslated region of amyloid precursor protein mRNA plays a key role in the regulation of translation and the binding of proteins. Mol. Cell. Biol. 2000, 20:4572-4579.
122. Mestdagh P., Feys T., Bernard N., Guenther S., Chen C., Speleman F., Vandesompele J. High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA. Nucleic Acids Res. 2008, 36:e143.
123. Mestdagh P., Van Vlierberghe P., De Weer A., Muth D., Westermann F., Speleman F., Vandesompele J. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol. 2009, 10:R64.
124. Miranda K.C., Huynh T., Tay Y., Ang Y.-S., Tam W.-L., Thomson A.M., Lim B., Rigoutsos I. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 2006, 126:1203-1217.
125. Miska E.A., Alvarez-Saavedra E., Townsend M., Yoshii A., Sestan N., Rakic P., Constantine-Paton M., Horvitz H.R. Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol. 2004, 5:R68.
126. Morin R.D., O'Connor M.D., Griffith M., Kuchenbauer F., Delaney A., Prabhu A.-L., Zhao Y., McDonald H., Zeng T., Hirst M., Eaves C.J., Marra M.A. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res. 2008, 18:610-621.
127. Mortensen R.D., Serra M., Steitz J.A., Vasudevan S. Posttranscriptional activation of gene expression in Xenopus laevis oocytes by microRNA-protein complexes (microRNPs). Proc. Natl. Acad. Sci. U. S. A. 2011, 108:8281-8286.
128. Mourelatos Z., Dostie J., Paushkin S., Sharma A., Charroux B., Abel L., Rappsilber J., Mann M., Dreyfuss G. miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev. 2002, 16:720-728.
129. Nelson P.T., Wang W.-X. MiR-107 is reduced in Alzheimer's disease brain neocortex: validation study. J. Alzheimers Dis. 2010, 21:75-79.
130. Nelson P.T., Wilfred B.R. In situ hybridization is a necessary experimental complement to microRNA (miRNA) expression profiling in the human brain. Neurosci. Lett. 2009, 466:69-72.
131. Nelson P.T., Baldwin D.A., Kloosterman W.P., Kauppinen S., Plasterk R.H.A., Mourelatos Z. RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain. RNA 2006, 12:187-191.
132. Nelson P.T., De Planell-Saguer M., Lamprinaki S., Kiriakidou M., Zhang P., O'Doherty U., Mourelatos Z. A novel monoclonal antibody against human Argonaute proteins reveals unexpected characteristics of miRNAs in human blood cells. RNA 2007, 13:1787-1792.
133. Nelson P.T., Wang W.-X., Wilfred B.R., Tang G. Technical variables in high-throughput miRNA expression profiling: much work remains to be done. Biochim. Biophys. Acta 2008, 1779:758-765.
134. Nelson P.T., Braak H., Markesbery W.R. Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship. J. Neuropathol. Exp. Neurol. 2009, 68:1-14.
135. Nelson P.T., Kiriakidou M., Mourelatos Z., Tan G.S., Jennings M.H., Xie K., Wang W.-X. High-throughput experimental studies to identify miRNA targets directly, with special focus on the mammalian brain. Brain Res. 2010, 1338:122-130.
136. Newman M.A., Mani V., Hammond S.M. Deep sequencing of microRNA precursors reveals extensive 3' end modification. RNA 2011, 17:1795-1803.
137. Nonne N., Ameyar-Zazoua M., Souidi M., Harel-Bellan A. Tandem affinity purification of miRNA target mRNAs (TAP-Tar). Nucleic Acids Res. 2010, 38:e20.
138. Nunez-Iglesias J., Liu C.C., Morgan T.E., Finch C.E., Zhou X.J. Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation. PLoS One 2010, 5:e8898.
139. Nunomura A., Hofer T., Moreira P.I., Castellani R.J., Smith M.A., Perry G. RNA oxidation in Alzheimer disease and related neurodegenerative disorders. Acta Neuropathol. 2009, 118:151-166.
140. Nuovo G.J. In situ detection of precursor and mature microRNAs in paraffin embedded, formalin fixed tissues and cell preparations. Methods 2008, 44:39-46.
141. Nuovo G.J., Elton T.S., Nana-Sinkam P., Volinia S., Croce C.M., Schmittgen T.D. A methodology for the combined in situ analyses of the precursor and mature forms of microRNAs and correlation with their putative targets. Nat. Protoc. 2009, 4:107-115.
142. Obad S., dos Santos C.O., Petri A., Heidenblad M., Broom O., Ruse C., Fu C., Lindow M., Stenvang J., Straarup E.M., Hansen H.F., Koch T., Pappin D., Hannon G.J., Kauppinen S. Silencing of microRNA families by seed-targeting tiny LNAs. Nat. Genet. 2011, 43:371-378.
143. Obernosterer G., Martinez J., Alenius M. Locked nucleic acid-based in situ detection of microRNAs in mouse tissue sections. Nat. Protoc. 2007, 2:1508-1514.
144. Orom U.A., Lund A.H. Isolation of microRNA targets using biotinylated synthetic microRNAs. Methods 2007, 43:162-165.
145. Ørom U.A., Kauppinen S., Lund A.H. LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene 2006, 372:137-141.
146. Ørom U.A., Nielsen F.C., Lund A.H. MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol. Cell 2008, 30:460-471.
147. Pena J.T.G., Sohn-Lee C., Rouhanifard S.H., Ludwig J., Hafner M., Mihailovic A., Lim C., Holoch D., Berninger P., Zavolan M., Tuschl T. miRNA in situ hybridization in formaldehyde and EDC-fixed tissues. Nat. Methods 2009, 6:139-141.
148. Peters L., Meister G. Argonaute proteins: mediators of RNA silencing. Mol. Cell 2007, 26:611-623.
149. Pollwein P., Masters C.L., Beyreuther K. The expression of the amyloid precursor protein (APP) is regulated by two GC-elements in the promoter. Nucleic Acids Res. 1992, 20:63-68.
150. Pradervand S., Weber J., Lemoine F., Consales F., Paillusson A., Dupasquier M., Thomas J., Richter H., Kaessmann H., Beaudoing E., Hagenbüchle O., Harshman K. Concordance among digital gene expression, microarrays, and qPCR when measuring differential expression of microRNAs. Biotechniques 2010, 48:219-222.
151. Pratt A.J., MacRae I.J. The RNA-induced silencing complex: a versatile gene-silencing machine. J. Biol. Chem. 2009, 284:17897-17901.
152. Quitschke W.W., Goldgaber D. The amyloid beta-protein precursor promoter. A region essential for transcriptional activity contains a nuclear factor binding domain. J. Biol. Chem. 1992, 267:17362-17368.
153. Raina P., Santaguida P., Ismaila A., Patterson C., Cowan D., Levine M., Booker L., Oremus M. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann. Intern. Med. 2008, 148:379-397.
154. Ray B., Chauhan N.B., Lahiri D.K. Oxidative insults to neurons and synapse are prevented by aged garlic extract and S-allyl-L-cysteine treatment in the neuronal culture and APP-Tg mouse model. J. Neurochem. 2011, 117:388-402.
155. Ray B., Long J.M., Sokol D.K., Lahiri D.K. Increased secreted amyloid precursor protein-α (sAPPα) in severe autism: proposal of a specific, anabolic pathway and putative biomarker. PLoS One 2011, 6:e20405.
156. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., Horvitz H.R., Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000, 403:901-906.
157. Rogers J.T., Leiter L.M., McPhee J., Cahill C.M., Zhan S.S., Potter H., Nilsson L.N. Translation of the Alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5'-untranslated region sequences. J. Biol. Chem. 1999, 274:6421-6431.
158. Rogers J.T., Randall J.D., Cahill C.M., Eder P.S., Huang X., Gunshin H., Leiter L., McPhee J., Sarang S.S., Utsuki T., Greig N.H., Lahiri D.K., Tanzi R.E., Bush A.I., Giordano T., Gullans S.R. An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript. J. Biol. Chem. 2002, 277:45518-45528.
159. Ruby J.G., Jan C., Player C., Axtell M.J., Lee W., Nusbaum C., Ge H., Bartel D.P. Large-scale sequencing reveals 21U-RNAs and additional microRNAs and endogenous siRNAs in C. elegans. Cell 2006, 127:1193-1207.
160. Sambamurti K., Greig N.H., Utsuki T., Barnwell E.L., Sharma E., Mazell C., Bhat N.R., Kindy M.S., Lahiri D.K., Pappolla M.A. Targets for AD treatment: conflicting messages from γ-secretase inhibitors. J. Neurochem. 2011, 117:359-374.
161. Sandberg R., Neilson J.R., Sarma A., Sharp P.A., Burge C.B. Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites. Science 2008, 320:1643-1647.
162. Schaefer A., O'Carroll D., Tan C.L., Hillman D., Sugimori M., Llinas R., Greengard P. Cerebellar neurodegeneration in the absence of microRNAs. J. Exp. Med. 2007, 204:1553-1558.
163. Scherr M., Venturini L., Battmer K., Schaller-Schoenitz M., Schaefer D., Dallmann I., Ganser A., Eder M. Lentivirus-mediated antagomir expression for specific inhibition of miRNA function. Nucleic Acids Res. 2007, 35:e149.
164. Schipper H.M., Maes O.C., Chertkow H.M., Wang E. MicroRNA expression in Alzheimer blood mononuclear cells. Gene Reg. Syst. Biol. 2007, 1:263-274.
165. Schneider L.S., Lahiri D.K. The perils of Alzheimer's drug development. Curr. Alzheimer Res. 2009, 6:77-78.
166. Schneider L.S., Insel P.S., Weiner M.W. Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative. Arch. Neurol. 2011, 68:58-66.
167. Schroeder A., Mueller O., Stocker S., Salowsky R., Leiber M., Gassmann M., Lightfoot S., Menzel W., Granzow M., Ragg T. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol. Biol. 2006, 7:3.
168. Selbach M., Schwanhäusser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455:58-63.
169. Sempere L.F., Freemantle S., Pitha-Rowe I., Moss E., Dmitrovsky E., Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 2004, 5:R13.
170. Sethi P., Lukiw W.J. Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex. Neurosci. Lett. 2009, 459:100-104.
171. Shao N.-Y., Hu H.Y., Yan Z., Xu Y., Hu H., Menzel C., Li N., Chen W., Khaitovich P. Comprehensive survey of human brain microRNA by deep sequencing. BMC Genomics 2010, 11:409.
172. Shi R., Chiang V.L. Facile means for quantifying microRNA expression by real-time PCR. Biotechniques 2005, 39:519-525.
173. Shingara J., Keiger K., Shelton J., Laosinchai-Wolf W., Powers P., Conrad R., Brown D., Labourier E. An optimized isolation and labeling platform for accurate microRNA expression profiling. RNA 2005, 11:1461-1470.
174. Silahtaroglu A.N., Nolting D., Dyrskjøt L., Berezikov E., Møller M., Tommerup N., Kauppinen S. Detection of microRNAs in frozen tissue sections by fluorescence in situ hybridization using locked nucleic acid probes and tyramide signal amplification. Nat. Protoc. 2007, 2:2520-2528.
175. Simpson D.A., Feeney S., Boyle C., Stitt A.W. Retinal VEGF mRNA measured by SYBR green I fluorescence: a versatile approach to quantitative PCR. Mol. Vis. 2000, 6:178-183.
176. Siomi H., Siomi M.C. Posttranscriptional regulation of microRNA biogenesis in animals. Mol. Cell 2010, 38:323-332.
177. Søe M.J., Møller T., Dufva M., Holmstrøm K. A sensitive alternative for microRNA in situ hybridizations using probes of 2'-O-methyl RNA + LNA. J. Histochem. Cytochem. 2011, 59:661-672.
178. Sokol D.K., Maloney B., Long J.M., Ray B., Lahiri D.K. Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links. Neurology 2011, 76:1344-1352.
179. Song W., Lahiri D.K. Functional identification of the promoter of the gene encoding the Rhesus monkey beta-amyloid precursor protein. Gene 1998, 217:165-176.
180. Sperling R.A., Dickerson B.C., Pihlajamaki M., Vannini P., LaViolette P.S., Vitolo O.V., Hedden T., Becker J.A., Rentz D.M., Selkoe D.J., Johnson K.A. Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med. 2010, 12:27-43.
181. Sun Y., Koo S., White N., Peralta E., Esau C., Dean N.M., Perera R.J. Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res. 2004, 32:e188.
182. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 1991, 30:572-580.
183. The Lancet Why are drug trials in Alzheimer's disease failing?. Lancet 2010, 376:658.
184. Thompson R.C., Deo M., Turner D.L. Analysis of microRNA expression by in situ hybridization with RNA oligonucleotide probes. Methods 2007, 43:153-161.
185. Válóczi A., Hornyik C., Varga N., Burgyán J., Kauppinen S., Havelda Z. Sensitive and specific detection of microRNAs by northern blot analysis using LNA-modified oligonucleotide probes. Nucleic Acids Res. 2004, 32:e175.
186. van Rooij E. The art of microRNA research. Circ. Res. 2011, 108:219-234.
187. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3:1-12.
188. Várallyay E., Burgyán J., Havelda Z. Detection of microRNAs by Northern blot analyses using LNA probes. Methods 2007, 43:140-145.
189. Vasudevan S., Tong Y., Steitz J.A. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007, 318:1931-1934.
190. Vermeulen A., Robertson B., Dalby A.B., Marshall W.S., Karpilow J., Leake D., Khvorova A., Baskerville S. Double-stranded regions are essential design components of potent inhibitors of RISC function. RNA 2007, 13:723-730.
191. Vilardo E., Barbato C., Ciotti M., Cogoni C., Ruberti F. MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons. J. Biol. Chem. 2010, 285:18344-18351.
192. Vostrov A.A., Taheny M.J., Izkhakov N., Quitschke W.W. A nuclear factor-binding domain in the 5'-untranslated region of the amyloid precursor protein promoter: implications for the regulation of gene expression. BMC Res. Notes 2010, 3:4.
193. Wan G., Lim Q.E., Too H.-P. High-performance quantification of mature microRNAs by real-time RT-PCR using deoxyuridine-incorporated oligonucleotides and hemi-nested primers. RNA 2010, 16:1436-1445.
194. Wang H., Ach R.A., Curry B. Direct and sensitive miRNA profiling from low-input total RNA. RNA 2007, 13:151-159.
195. Wang W.X., Rajeev B.W., Stromberg A.J., Ren N., Tang G., Huang Q., Rigoutsos I., Nelson P.T. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J. Neurosci. 2008, 28:1213-1223.
196. Wang Y., Sheng G., Juranek S., Tuschl T., Patel D.J. Structure of the guide-strand-containing argonaute silencing complex. Nature 2008, 456:209-213.
197. Wang W.-X., Wilfred B.R., Hu Y., Stromberg A.J., Nelson P.T. Anti-Argonaute RIP-Chip shows that miRNA transfections alter global patterns of mRNA recruitment to microribonucleoprotein complexes. RNA 2010, 16:394-404.
198. Wang W.-X., Wilfred B.R., Madathil S.K., Tang G., Hu Y., Dimayuga J., Stromberg A.J., Huang Q., Saatman K.E., Nelson P.T. miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease. Am. J. Pathol. 2010, 177:334-345.
199. Wightman B., Ha I., Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993, 75:855-862.
200. Winter J., Diederichs S. Argonaute proteins regulate microRNA stability: increased microRNA abundance by Argonaute proteins is due to microRNA stabilization. RNA Biol. 2011, 8.
201. Yeom K.-H., Heo I., Lee J., Hohng S., Kim V.N., Joo C. Single-molecule approach to immunoprecipitated protein complexes: insights into miRNA uridylation. EMBO Rep. 2011, 12:690-696.
202. Zaidi S.H., Malter J.S. Amyloid precursor protein mRNA stability is controlled by a 29-base element in the 3'-untranslated region. J. Biol. Chem. 1994, 269:24007-24013.
203. Zaidi S.H., Denman R., Malter J.S. Multiple proteins interact at a unique cis-element in the 3'-untranslated region of amyloid precursor protein mRNA. J. Biol. Chem. 1994, 269:24000-24006.
204. Zhang C., Darnell R.B. Mapping in vivo protein-RNA interactions at single-nucleotide resolution from HITS-CLIP data. Nat. Biotechnol. 2011, 29:607-614.
205. Zhao J.-J., Hua Y.-J., Sun D.-G., Meng X.-X., Xiao H.-S., Ma X. Genome-wide microRNA profiling in human fetal nervous tissues by oligonucleotide microarray. Childs Nerv. Syst. 2006, 22:1419-1425.
206. Zhao Y., Ransom J.F., Li A., Vedantham V., von Drehle M., Muth A.N., Tsuchihashi T., McManus M.T., Schwartz R.J., Srivastava D. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 2007, 129:303-317.